期刊文献+

重组精氨酸脱亚胺酶的酶活性测定 被引量:1

Enzyme Activity Determination of Recombinant Arginine Deiminase
原文传递
导出
摘要 建立了大肠杆菌表达的重组精氨酸脱亚胺酶(1)的酶活性体外测定方法。通过优化反应体积、底物浓度、反应时间、反应液pH值等参数,确定测定重组1酶活性的最佳条件为:底物精氨酸浓度20 mmol/L、pH 6.5、反应时间20 min、反应体积100ul(试管法)。本法的线性范围为10~25ug/ml,变异系数(CV)小于10%。 An assay method was established for the enzyme activity determination of recombinant arginine deiminase (ADI) expressed by E. coli. The effects of reaction solution volume, substrate concentration, reaction time and pH value of reaction solution on enzyme activity were investigated. The optimized conditions were as follows: 20 mmol/L arginine, pH 6.5, reaction time of 20 min and reaction volume of 100 μl (test tube method). The calibration curve of ADI was linear in the range of 10 - 25 μg/ml with CV less than 10%.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2014年第10期968-970,共3页 Chinese Journal of Pharmaceuticals
基金 国家重大科学仪器设备开发专项(2011YQ15007208) 上海市经信委引进技术的消化吸收专题(12XI-09)
关键词 精氨酸脱亚胺酶 酶活性 测定 arginine deiminase enzyme activity determination
  • 相关文献

参考文献5

  • 1Zú?iga M,Pérez G,González-Candelas F.Evolution of arginine deiminase(ADI) pathway genes [J].Mol Phylogenet Evol,2002,25(3): 429-444.
  • 2Stalon V,Simon JP,Mercenier A.Enzymes of arginine utilization and their formation in Aeromonas formicans NCIB 9232 [J].Arch Microbiol,1982,133(4): 295-299.
  • 3Monstadt GM,Holldorf AW.Arginine deiminase from Halobacterium salinarium.Purification and properties [J].Biochem J,1991,273(Pt3): 739-745.
  • 4Takaku H,Takase M,Abe S,et al.In vivo anti-tumor activity of arginine deiminase purified from Mycoplasma arginini [J].Int J Cancer,1992,51(2): 244-249.
  • 5上海医药工业研究院.关节炎型支原体精氨酸脱亚胺酶突变体及其应用: 中国,201310159336.8 [P].2013-05-03.

同被引文献7

  • 1Ensor CM, Holtsberg FW, Bomalaski JS, et al. Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo[J].Cancer Res, 2002, 62 (19) : 5443-5450.
  • 2Syed N, Langer J, Janczar K, et al. Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma [J]. Cell Death Dis, 2013, 4(1): e458.
  • 3Kim RH, Coates JM, Bowles TL, et al. Arginine deiminase as anovel therapy for prostate cancer induces autophagy and caspase-independent apoptosis [J]. Cancer Res, 2009, 69 (2) : 700-708.
  • 4Glazer ES, Piccirillo M, Albino V, et al. Phase Ⅱ study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma [J]. J Clin Oncol, 2010, 28 (13): 2220-2226.
  • 5Yang TS, Lu SN, Chao Y, et al. A randomised phase Ⅱ study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients [J]. Br J Cancer, 2010, 103 (7) : 954-960.
  • 6Ott PA, Carvajal RD, Pandit-Taskar N, et al. Phase I/Ⅱ study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma [J]. Invest New Drugs, 2013, 31 (2) : 425-434.
  • 7冯秀萍,于乐洋,闫东梅,杜柏榕,朱迅.重组人胸腺素β16工程菌株的遗传稳定性研究[J].中国生化药物杂志,2009,30(1):10-13. 被引量:2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部